Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | -0.74% | -8.14% | +6.80% |
05-15 | Transcript : OncoCyte Corporation, Q1 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (OCX) ONCOCYTE CORPORATION Reports Q1 Revenue $176,000, vs. Street Est of $0.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.80% | 35.95M | |
-39.46% | 8.68B | |
-2.85% | 3.2B | |
+13.16% | 2.71B | |
-18.81% | 2.04B | |
-24.03% | 1.64B | |
+37.10% | 1.43B | |
-7.86% | 718M | |
-27.35% | 538M | |
-8.35% | 287M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Sector Update: Health Care Stocks Edging Higher, Boosted by Recent Gains in Biotech Shares